Skip to main
TRAW
TRAW logo

Traws Pharma (TRAW) P/E Ratio

P/E Ratio as of Jun 13, 2025: -0.02

Average-0.0140
Median-0.0100
Minimum-0.0200
Maximum-0.0100
-0.02
Past Month-0.01 (100.00%)
The P/E ratio for Traws Pharma (TRAW) is -0.02 as of Jun 13, 2025. This represents a decrease of -50.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Traws Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Traws Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Traws Pharma to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Traws Pharma (TRAW) P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$1.42-0.01
May 1, 2025$1.41-0.01
Apr 1, 2025$2.14-0.02
Mar 3, 2025$2.29-0.02
Feb 3, 2025$7.49-0.05
Jan 2, 2025$8.67-0.06

Traws Pharma (TRAW) End of Year P/E Ratio

DateP/E ratioChange
2025-0.02-66.67%
2024-0.06-92.21%
2023-0.77-1.28%
2022-0.78-69.77%
2021-2.58-19.88%
2020-3.22

FAQs About Traws Pharma (TRAW) P/E ratio

The latest P/E ratio of Traws Pharma (TRAW) is -0.02, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Traws Pharma’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.02. This reflects a decrease of -50.00%.

Traws Pharma’s current P/E ratio of -0.02 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Traws Pharma’s average P/E ratio over the last 3 years is -0.69. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Traws Pharma’s average P/E ratio over the last 5 years is -1.58. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Traws Pharma (TRAW)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.